Anavex Life Sciences Corp (AVXL)

[pcguy]

A2-73 targets more muscarinic receptors than A3-71, and both sigma 1. There is a reason A3-71 only targets M1 muscarinic receptors. Did Missling state these could be a combo therapy? I would be curious about the reasoning considering the research to this point would not be supportive of the combination of these two drugs as being synergistic.